Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy.
作者信息
Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A, Takatsu Y
出版信息
Heart. 2003 Jun;89(6):659-60. doi: 10.1136/heart.89.6.659.
Abstract
摘要
相似文献
1
Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy.
Heart. 2003 Jun;89(6):659-60. doi: 10.1136/heart.89.6.659.
2
Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2013 Oct 1;62(14):1252-1259. doi: 10.1016/j.jacc.2013.03.055. Epub 2013 Apr 23.
3
Obstructive cardiomyopathy with persistent marked elevation of troponin T in myasthenia gravis.
Int J Cardiol. 2016 Jan 15;203:128-30. doi: 10.1016/j.ijcard.2015.10.152. Epub 2015 Oct 19.
4
Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
Swiss Med Wkly. 2016 Mar 21;146:w14285. doi: 10.4414/smw.2016.14285. eCollection 2016.
5
Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
J Cardiol. 2014 Feb;63(2):140-4. doi: 10.1016/j.jjcc.2013.07.008. Epub 2013 Sep 4.
6
Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
BMC Cardiovasc Disord. 2015 Jun 16;15:53. doi: 10.1186/s12872-015-0043-z.
7
Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk.
Am J Cardiol. 2014 Apr 1;113(7):1240-5. doi: 10.1016/j.amjcard.2013.12.033. Epub 2014 Jan 16.
8
Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy.
J Card Fail. 2010 Dec;16(12):950-6. doi: 10.1016/j.cardfail.2010.07.245.
9
Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Am J Cardiol. 2013 Sep 15;112(6):867-72. doi: 10.1016/j.amjcard.2013.04.060. Epub 2013 Jun 6.
10
[High-sensitivity cardiac troponin T and hemodialysis: influence of gender, age and diabetes].
Ann Biol Clin (Paris). 2018 Apr 1;76(2):237-238. doi: 10.1684/abc.2018.1329.
引用本文的文献
1
Evaluation of Pediatric Cardiomyopathy Patients in Pediatric Intensive Care Unit.
Turk Arch Pediatr. 2025 Sep 1;60(5):515-523. doi: 10.5152/TurkArchPediatr.2025.25111.
2
High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy.
Eur J Med Res. 2025 Jan 23;30(1):50. doi: 10.1186/s40001-024-02222-7.
3
Cytokeratin 18 as a Novel Biomarker in Patients with Hypertrophic Cardiomyopathy.
Cells. 2024 Aug 9;13(16):1328. doi: 10.3390/cells13161328.
4
The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.
Am J Cardiovasc Drugs. 2022 Sep;22(5):497-510. doi: 10.1007/s40256-022-00532-x. Epub 2022 Apr 18.
5
Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury.
J Clin Med. 2021 May 26;10(11):2331. doi: 10.3390/jcm10112331.
6
Characterization of troponin I levels post synchronized direct current cardioversion of atrial arrhythmias in patients with and without cardiomyopathy.
J Interv Card Electrophysiol. 2021 Mar;60(2):329-335. doi: 10.1007/s10840-020-00814-x. Epub 2020 Jul 3.
7
Significance of NT-proBNP and High-sensitivity Troponin in Friedreich Ataxia.
J Clin Med. 2020 May 28;9(6):1630. doi: 10.3390/jcm9061630.
8
Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders.
J Mol Cell Cardiol. 2020 Jun;143:145-158. doi: 10.1016/j.yjmcc.2020.05.010. Epub 2020 May 19.
9
Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP.
Dis Markers. 2019 Jun 20;2019:6487152. doi: 10.1155/2019/6487152. eCollection 2019.
10
A One Health Approach to Hypertrophic Cardiomyopathy.
Yale J Biol Med. 2017 Sep 25;90(3):433-448. eCollection 2017 Sep.
本文引用的文献
1
Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes.
Circulation. 2001 Jan 23;103(3):369-74. doi: 10.1161/01.cir.103.3.369.
2
Cardiac troponins: IT upgrade for the heart.
Lancet. 1998 Feb 21;351(9102):537-9. doi: 10.1016/S0140-6736(05)78549-4.
3
Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy.
Heart. 1997 Nov;78(5):505-8. doi: 10.1136/hrt.78.5.505.
4
The management of hypertrophic cardiomyopathy.
N Engl J Med. 1997 Mar 13;336(11):775-85. doi: 10.1056/NEJM199703133361107.
5
Mechanism and significance of myocardial uptake of antimyosin antibody in myocarditis and cardiomyopathy: clinical and experimental studies.
Clin Immunol Immunopathol. 1993 Aug;68(2):215-9. doi: 10.1006/clin.1993.1121.
Zotero 插件